سعر كلاتازيف 60 مجم 28 قرص مغلف 2026

Clatazev 60 mg film-coated tablets, 28 tablets (daclatasvir). BMS via Egyptian Pharmaceutical Trading Company. Direct-acting antiviral (HCV NS5A inhibitor), used in combination regimens.

• Treatment of chronic hepatitis C virus (HCV) infection in adults, always in combination with other antiviral medicinal products (regimen depends on HCV genotype and patient factors) — per EMA Daklinza SmPC.Population: Adults with chronic HCVEuropean Medicines Agency (EMA)

• Hypersensitivity to the active substance or excipients; co-administration with strong inducers of CYP3A (e.g., rifampicin, phenytoin, carbamazepine, systemic dexamethasone, St John's wort) — per EMA Daklinza.International label, equivalent formulation · European Medicines Agency (EMA)

• Risk of HBV reactivation in HBV/HCV co-infected patients. Bradycardia with sofosbuvir plus amiodarone. Must not be used as monotherapy.International label, equivalent formulation · European Medicines Agency (EMA)

• Daklinza: embryotoxic/teratogenic in animals; not to be used in pregnancy; effective contraception required during and for 5 weeks after treatment (and companion drugs may have additional requirements).International label, equivalent formulation · European Medicines Agency (EMA)
• Mothers should not breast-feed during treatment (EMA Daklinza).International label, equivalent formulation · European Medicines Agency (EMA)

• Daclatasvir: Inhibits HCV non-structural protein 5A (NS5A), an essential component of the viral replication complex, blocking viral RNA replication and virion assembly.